Cargando…
A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-κB Signaling
BACKGROUND: Viral myocarditis, which is most prevalently caused by Coxsackievirus B3 (CVB3) infection, is a serious clinical condition characterized by cardiac inflammation. However, efficient therapies targeting inflammation are still lacking and much needed. A20, also known as tumor necrosis facto...
Autores principales: | Gui, Jun, Yue, Yan, Chen, Ruizhen, Xu, Wei, Xiong, Sidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460927/ https://www.ncbi.nlm.nih.gov/pubmed/23029542 http://dx.doi.org/10.1371/journal.pone.0046515 |
Ejemplares similares
-
Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation
por: Gui, Jun, et al.
Publicado: (2015) -
Monocytic myeloid-derived suppressor cells from females, but not males, alleviate CVB3-induced myocarditis by increasing regulatory and CD4(+)IL-10(+) T cells
por: Su, Nan, et al.
Publicado: (2016) -
An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine
por: Gao, Yue, et al.
Publicado: (2021) -
Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis
por: Yang, Xiaoli, et al.
Publicado: (2019) -
Direct Gene Transfer with IP-10 Mutant Ameliorates Mouse CVB3-Induced Myocarditis by Blunting Th1 Immune Responses
por: Yue, Yan, et al.
Publicado: (2011)